PEN (Penumbra) Marketable Securities: $374 Mil (As of Mar. 2026)


PEN Penumbra Inc PEN
88 GF Score
Price $317.28
GF Value $332.37
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Penumbra Marketable Securities?

Penumbra PEN -0.32% 88 Marketable Securities is $374 Mil as of Mar. 2026. GuruFocus rates PEN with a GF Score™ of 88/100 and a GF Value™ of $332.37 (Fairly Valued). The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Penumbra's Marketable Securities for the quarter that ended in Mar. 2026 was $374 Mil.

Penumbra's annual Marketable Securities declined from Dec. 2023 ($122 Mil) to Dec. 2024 ($16 Mil) but then increased from Dec. 2024 ($16 Mil) to Dec. 2025 ($358 Mil).

Penumbra  (NYSE:PEN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Penumbra Marketable Securities Related Terms

Penumbra Marketable Securities Historical Data

* Premium members only.

The historical data trend for Penumbra's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Penumbra Marketable Securities Chart

Penumbra Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 195.50 118.17 121.70 15.73 357.92

Penumbra Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.79 2.80 149.27 357.92 374.37
PEN
88GF Score
Penumbra Inc PEN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Penumbra Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $374 Mil mean?
Penumbra (PEN) has a Marketable Securities of $374 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Penumbra and its competitors.
Is Penumbra's Marketable Securities too high?
Penumbra's current Marketable Securities is $374 Mil. Overall, Penumbra has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Penumbra's Marketable Securities compare to GMED and PODD?
Penumbra's Marketable Securities of $374 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Penumbra and its competitors. Penumbra's current Marketable Securities is $374 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Based on GuruFocus' analysis, Penumbra (PEN) is currently considered Fairly Valued. The stock's GF Value™ is $332.37, compared to a current price of $317.28 — trading 4.5% below its estimated fair value. The current Marketable Securities is $374 Mil. Penumbra's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Penumbra (PEN), the current Marketable Securities is $374 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Penumbra (PEN) Overvalued in 2026?

Based on GuruFocus' analysis, Penumbra stock appears to be undervalued. The current stock price of $317.28 is trading 4.5% below its estimated GF Value™ of $332.37. GuruFocus considers Penumbra to be Fairly Valued.

Key valuation signals for PEN:

  • Marketable Securities: $374 Mil
  • GF Value™: $332.37 vs. price of $317.28 (4.5% below fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the PEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Penumbra Business Description

Other Exchanges 0P8:Germany
Address 1310 Harbor Bay Parkway, One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
88GF Score

Get the complete analysis for PEN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$317.28
Price
$332.37
GF Value